-Sarika Sarakinti, Edited by Prashasti Sharma
Management of diabetes has changed immensely in the last few years, thanks to technologies like Continuous Glucose Monitoring (CGM). CGM monitors the amount of glucose in the body almost all the time (every few minutes), giving feedback on how blood sugar goes up and comes down throughout the day and at night. This helps physicians and patients make better decisions. In this we explore how effective CGM is, what are the benefits, and how much still needs to be addressed.
What is CGM Success Rate?
“Success rate” means many different things: how well the device is accurate, how well it improves things for blood sugar management, and how many people stick with it.
- Accuracy: CGM sensors have improved in recent years. The mean absolute relative difference (MARD) – a common measure of how close are CGM values to reference (blood) glucose has fallen, showing that the sensors become increasingly trustworthy.
- Improvement of glucose control: Studies have found that patients who use CGM, especially those with poorly controlled diabetes (type 1 and type 2), have better results. These are lower HbA1c (a measure of average blood sugar over time), more time in target glucose range, less time in hypoglycemia (low sugar, potentially harmful), less frequency of hyperglycemia (high sugar, very high).
- Reproducibility/consistency: There has also been some research into how day-to-day consistent CGM readings are. For example, one large study found that in diabetes, daytime readings are more day-to-day consistent than when non-diabetes is present.
- Adherence / Acceptability: Also depends on whether people will keep using the CGM properly. If technology is painful, or costly, or information hard to interpret, then people stop sticking with it and miss out on benefits.
In general then, CGM is very successful in making blood sugar better and reducing risk, if people keep using it and the technology is good.
Benefits of CGM :
Following are the main advantages of CGM, according to published studies and clinical experience:
- Enhanced blood glucose control
- More information than fingerstick. Trends are apparent: is glucose rising after meals? decreasing at night? This translates to faster corrective intervention. It lowers HbA1c.
- Reduced hypoglycemia and hyperglycemia
- Since CGM has ongoing readings, it will warn users (and, occasionally, caregivers) in advance if glucose is at risk of going too high or too low. This reduces risky episodes.
- Improved “time in range”
- While doctors once looked only at HbA1c, now they are more likely to monitor how long a person’s glucose stays within a desired range (say, 70-180 mg/dL). More time spent in range means fewer highs and lows. CGM improves this measurement.
- Enhanced patient engagement and quality of life
- Access to real-time glucose data can help patients make changes in diet, exercise, insulin dosage, and feel more in control. It removes ambiguity. Some studies note higher satisfaction with care.
- Complication prevention
- By keeping blood sugar in the vicinity of normal, CGM can prevent late complications (such as kidney, eye, nerve damage) as well as reduce hospitalization for severe episodes.
- Helpful in type 2 diabetes as well
- Although CGM has been used extensively in type 1 diabetes, evidence is coming out that patients with type 2 diabetes benefit whether they receive insulin or not.
Challenges and Limitations:
No technology is perfect. CGM is not without challenges which limit its success and use in some populations or settings.
- Cost: Devices and sensors are expensive. They may be uncovered in certain areas or health systems, so access is limited. This is one of the biggest obstacles.
- Wearability and comfort: The sensor will need to be strapped to the skin (typically with adhesives) and need to be replaced eventually. Some people object to the adhesive as it is annoying, or the sensor as being bulky or
injurious. Dermatitis and discomfort can act as a spoiler.
- Visibility and social or psychological concerns: A few do not prefer that the sensor is visible; it becomes stigmatic to wear it. Data overload and continuous alarms can also cause anxiety.
- Some inaccuracy in some instances: Accuracy is well and good in general, but there can be inaccuracy with rapid glucose fluctuations (e.g. after meals or intense exercise), or with sensor pressure, or with sensors that are not well-calibrated. Additionally, some devices lag behind actual blood glucose, as they are measuring glucose in interstitial fluid, not identical to blood.
- Data interpretation and handling: CGM creates a lot of information. Good user and clinician training, as well as good software programs, are needed to interpret patterns as opposed to random numbers. In other words, data can be under utilized otherwise.
- Issues with adherence: As noted, benefits are lost if users don’t wear the sensor daily, or don’t respond to alarms, or don’t react to the information. Studies recognize gaps in data usage with worse outcomes.
- Equity and accessibility: Cost, availability, and infrastructure (i.e. internet, clinics with trained staff) limit CGM in the majority of low- and middle-income countries. Insurance or health system subsidy differ significantly.
- Practical Considerations / What Enhances Success
- The following from the literature are identified to increase how well CGM functions:
- Selecting a CGM device that has accuracy and function to be good (alarms, data logging).
- Proper patient education: learning to read trends, respond to alarms, adjust lifestyle.
- Frequent follow-up with healthcare providers to share CGM information and adjust treatment.
- Support systems: peer support, apps, sensor replacement reminders.
- Making devices and supplies affordable / financially supported by healthcare systems.
Conclusion:
Continuous glucose monitoring is a powerful tool in modern diabetes management. It has a history of enabling patients to decrease HbA1c, remain within healthy glucose levels for longer, and avoid dangerous glucose highs and lows. It enables better decision-making, active participation, and possibly fewer complications. But its promise depends upon overcoming challenges: expense, accessibility, precision in difficult situations, and making sure people can use it properly. With continued innovation in sensor technology, greater availability, and quality education, CGM can be even more effective.
SOURCES:
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4717493/
- https://diabetesjournals.org/clinical/article/43/1/139/157329/Continuous-Glucose-Monitori
ng-in-Individuals-With
- https://link.springer.com/article/10.1007/s13300-025-01769-w
- https://academic.oup.com/intqhc/article/37/3/mzaf046/8127067
- https://e-dmj.org/journal/view.php?doi=10.4093/dmj.2019.0121
- https://www.nature.com/articles/s41598-023-40949-1
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10460137/